West Pharmaceutical Services Inc (BSP:W2ST34)
R$ 55.16 0.16 (0.29%) Market Cap: 139.83 Bil Enterprise Value: 138.71 Bil PE Ratio: 48.32 PB Ratio: 8.58 GF Score: 91/100

West Pharmaceutical Services Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 10:20PM GMT
Casey Rene Woodring
JPMorgan Chase & Co, Research Division - Research Analyst

Hi, everyone. Welcome to the 2021 JPMorgan Healthcare Conference. My name is Casey Woodring. I'm a member of the life science tools and diagnostics equity research team here at JPMorgan.

Today, it is my pleasure to introduce the management team from West Pharmaceutical Services. As a reminder, if you would like to ask a question, please feel free to submit via the presentation web page.

And with that, let me turn it over to Eric.

Eric M. Green
West Pharmaceutical Services, Inc. - President, CEO & Director

Great. Casey, thank you. Thank you for the introduction, and thank you to JPMorgan for hosting us at this year's conference. And we hope that next year, sure, all would agree that we would like to be able to see everyone in person in San Francisco.

Today, I have a few slides like to share with you and walk through and -- on the exciting work being done here at West. And then our CFO, Bernard Birkett, will join me in the Q&A session

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot